| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.7M | +20.5% |
| R&D Expense | $163K | — |
| SG&A Expense | $7.6M | -27.8% |
| Operating Income | -$6.6M | +43.9% |
| Net Income | -$3.6M | +66.8% |
| EPS (Basic) | -$0.10 | +64.3% |
| EPS (Diluted) | -$0.10 | +64.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.3M | +46.1% |
| Short-term Investments | $56.5M | -19.3% |
| Accounts Receivable | $529K | +627.8% |
| Current Assets | $78.3M | -4.9% |
| Total Assets | $112.0M | +14.6% |
| Current Liabilities | $12.0M | +262.4% |
| Total Liabilities | $18.6M | +89.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.1M | +25.6% |
| Capital Expenditures | $378K | +751.8% |
| Investing Cash Flow | $6.1M | +108.7% |
| Financing Cash Flow | $7.1M | +1270.6% |
| Free Cash Flow | -$8.5M | +22.4% |
| Stockholders' Equity |
| $82.7M |
| -5.9% |